Skip to content
Trial Eligibility
Menu

A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases

NCT07780890

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The overall goal of this study is to develop Brillouin microscope as a novel tool for measuring biomechanical and hydration properties of human tissues in vivo.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Fuchs Endothelial Corneal Dysfunction
  • Open Angle Glaucoma (OAG)
  • Dry Eye Disease (DED)
  • Keratoconus
  • Lasik Eye Surgery

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
20 to 79 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Massachusetts General Hospital
Last updated on ClinicalTrials.gov
August 25, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Massachusetts General Brigham · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.